GRCE insider buying

11 cluster buys

Grace Therapeutics, Inc.

When two or more insiders at Grace Therapeutics, Inc. buy GRCE in a qualifying detection window, the grouped purchases provide a starting point for further research. Below is every cluster we've detected in GRCE plus the full record of qualifying open-market buys, each parsed directly from Form 4 filings and linked back to the source on SEC EDGAR.

Clusters
11
Distinct insiders
2
Total bought
$839.2K
Market cap
Unknown

Detected clusters

  • Aug 14 – Nov 5, 2026
    Detected Nov 6, 2026
    Executive buyer2 insiders
    Total bought
    $839.2K
    Market cap
    Unknown
  • Aug 14 – Oct 26, 2026
    Detected Oct 26, 2026
    Executive buyer2 insiders
    Total bought
    $806.2K
    Market cap
    Unknown
  • Aug 14 – Oct 19, 2026
    Detected Oct 21, 2026
    Executive buyer2 insiders
    Total bought
    $647.6K
    Market cap
    Unknown

8 more clusters in GRCE

Choose Basic for full history, or Pro for email and Telegram alerts after new insider clusters are detected. Both plans start with a 7-day trial.

All notable open-market buys in GRCE

Every open-market Form 4 purchase, newest first. Click an insider to see their full buying record across companies.

DateInsiderSharesPriceValueFiling
Nov 5, 2026
10% Owner
3,087$1.77$5.5KSEC ↗
Nov 4, 2026
10% Owner
5,027$1.80$9.1KSEC ↗
Nov 3, 2026
10% Owner
10,328$1.79$18.5KSEC ↗
Oct 26, 2026
10% Owner
66,411$1.77$117.4KSEC ↗
Oct 22, 2026
10% Owner
21,390$1.93$41.2KSEC ↗
Oct 19, 2026
10% Owner
4,256$1.88$8.0KSEC ↗
Oct 16, 2026
10% Owner
36,347$1.89$68.8KSEC ↗
Oct 15, 2026
10% Owner
23,485$1.95$45.7KSEC ↗
Oct 14, 2026
10% Owner
11,233$1.93$21.7KSEC ↗
Oct 12, 2026
10% Owner
7,215$2.02$14.6KSEC ↗
Oct 9, 2026
10% Owner
5,340$2.04$10.9KSEC ↗
Oct 8, 2026
10% Owner
2,077$2.02$4.2KSEC ↗
Oct 5, 2026
10% Owner
1,694$2.06$3.5KSEC ↗
Oct 2, 2026
10% Owner
20,000$2.07$41.4KSEC ↗
Oct 1, 2026
10% Owner
38,796$2.04$79.0KSEC ↗
Sep 29, 2026
10% Owner
7,849$2.09$16.4KSEC ↗
Sep 23, 2026
10% Owner
5,318$2.10$11.2KSEC ↗
Sep 23, 2026
10% Owner
5,318$2.10$11.2KSEC ↗
Sep 21, 2026
10% Owner
9,771$2.10$20.5KSEC ↗
Sep 21, 2026
10% Owner
9,771$2.10$20.5KSEC ↗
Sep 9, 2026
Director, Chief Executive Officer
100,000$2.14$214.0KSEC ↗
Sep 9, 2026
10% Owner
5,836$2.09$12.2KSEC ↗
Sep 8, 2026
10% Owner
9,393$2.10$19.7KSEC ↗
Aug 14, 2026
10% Owner
11,608$2.09$24.2KSEC ↗

GRCE insider buying — FAQ

Are insiders buying GRCE stock?
Yes — 2 distinct insiders have bought GRCE (Grace Therapeutics, Inc.) on the open market, including 11 cluster buys where two or more insiders bought within a rolling window. The most recent qualifying activity was Nov 6, 2026.
How much GRCE stock have insiders bought?
Insiders have bought a combined $839.2K of GRCE across 24 open-market purchases, based on SEC Form 4 filings.
What is an insider cluster buy in GRCE?
A cluster buy is two or more distinct Grace Therapeutics, Inc. insiders — officers, directors, or 10% owners — each buying GRCE on the open market within a rolling window. GRCE has 11 detected cluster buys to date.
Where does this GRCE insider trading data come from?
Every figure is parsed directly from SEC Form 4 filings on EDGAR, and each purchase on this page links back to its original filing document.

How we track insider buying in GRCE

We continuously poll SEC EDGAR for new Form 4 filings and parse every open-market purchase (transaction code P). A cluster is recorded when two or more distinct insiders — officers, directors, or 10% owners — each buy GRCE within a rolling window. We track clusters at every company size, from micro-caps to mega-caps. Transactions link to official filings; prices and market capitalizations may be cached market data. Read our methodology and data limits before interpreting the figures. What counts as a cluster buy?

This page is informational and reflects public filing data. It is not investment advice or a recommendation regarding GRCE.